CIK 0001610820 · Non-accelerated filer<br>Smaller reporting company
BriaCell Therapeutics Corp.
Sign in to watch- Ticker
- BCTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jul 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 921-1810
- Business address
- 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, British Columbia, Canada, V7T 2X1
- Former names
- Ansell Capital Corp.
Securities
- BCTX Common Shares Nasdaq
- BCTXL Warrants Nasdaq
- BCTXZ Warrant Nasdaq
- 10-K Report Annual Report
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale · Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Delisting notice
- 8-K Event Regulation FD disclosure
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 902,935 shares at $2.22 ($2,000,001)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
Page 6 of 17 · 324 filings